BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2289534)

  • 1. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.
    Reith ME
    Eur J Pharmacol; 1990 Sep; 186(2-3):327-30. PubMed ID: 2289534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism.
    Svingos AL; Hitzemann R
    Pharmacol Biochem Behav; 1992 Nov; 43(3):871-9. PubMed ID: 1448481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens.
    McNeish CS; Svingos AL; Hitzemann R; Strecker RE
    Pharmacol Biochem Behav; 1993 Aug; 45(4):759-63. PubMed ID: 8415815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells.
    Idres S; Delarue C; Lefebvre H; Vaudry H
    Brain Res Mol Brain Res; 1991 Jun; 10(3):251-8. PubMed ID: 1653392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
    Middlefell VC; Price TL
    Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist effects at putative central 5-HT4 receptors in rat hippocampus by R(+)- and S(-)-zacopride; no evidence for stereo-selectivity.
    Boddeke HW; Kalkman HO
    Neurosci Lett; 1992 Jan; 134(2):261-3. PubMed ID: 1589153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype.
    Lefebvre H; Contesse V; Delarue C; Feuilloley M; Hery F; Grise P; Raynaud G; Verhofstad AA; Wolf LM; Vaudry H
    Neuroscience; 1992; 47(4):999-1007. PubMed ID: 1374544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of 5-hydroxytryptamine in the intestinal motor disturbances induced by mast cell degranulation in rats.
    Bueno L; Fargeas MJ; Theodorou V; Fioramonti J
    Eur J Pharmacol; 1991 Jan; 192(2):263-9. PubMed ID: 2032558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
    Bhandari P; Andrews PL
    Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zacopride and BRL 24924 induce an increase in EEG-energy in rats.
    Boddeke HW; Kalkman HO
    Br J Pharmacol; 1990 Oct; 101(2):281-4. PubMed ID: 2257436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zacopride, a potent 5-HT3 antagonist.
    Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
    J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat.
    Adrien J; Tissier MH; Lanfumey L; Haj-Dahmane S; Jolas T; Franc B; Hamon M
    Neuropharmacology; 1992 Jun; 31(6):519-29. PubMed ID: 1407392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM; Costall B; Naylor RJ
    J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists.
    Grant KA; Barrett JE
    Psychopharmacology (Berl); 1991; 104(4):451-6. PubMed ID: 1780414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.